{
    "clinical_study": {
        "@rank": "148017", 
        "arm_group": [
            {
                "arm_group_label": "Integra"
            }, 
            {
                "arm_group_label": "Integra + NPWT (short-inpatient use only)"
            }, 
            {
                "arm_group_label": "Integra + NPWT (long-all other durations)"
            }, 
            {
                "arm_group_label": "Integra + STSG"
            }, 
            {
                "arm_group_label": "Integra + Dermoinductive Agent"
            }, 
            {
                "arm_group_label": "Free Flap"
            }, 
            {
                "arm_group_label": "Local Tissue Flap"
            }, 
            {
                "arm_group_label": "NPWT"
            }, 
            {
                "arm_group_label": "NPWT then Integra (on same admission)"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a retrospective, multi-center study evaluating the outcomes of using Integra\u00ae skin\n      sheet bilayer or single layer products for complex soft tissue reconstruction of lower\n      extremity diabetic wounds compared to other treatments. Participating sites will collect\n      information for all patients who received Integra, free flap, local tissue flap, or negative\n      pressure therapy over a 5 year period. The patient must be a minimum of 1 year from index\n      procedure, with index procedure being defined as the application of Integra, free flap,\n      local tissue flap, or negative pressure. Any follow-up occurring during the year is eligible\n      for inclusion."
        }, 
        "brief_title": "Retrospective Study Evaluating Outcomes for Integra\u00ae Skin Sheet Products in Lower Extremity Complex Wounds", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetics Type I and II", 
            "Lower Extremity Complex Wounds (Exposed Deep Tissue- ex: Bone, Tendon, Fascia, Ligament)."
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diabetic (I or II) male or female, age greater than 18 years\n\n          -  Lower extremity wounds that required operative application of Integra, free flap,\n             local tissue flap, or negative pressure wound therapy.  Complex wounds are defined as\n             wounds that involve exposed deep tissue (e.g. bone, tendon, fascia, ligament)\n\n          -  The patient must be a minimum of 1 year from the index procedure, any follow-up\n             occurring during the year is eligible for inclusion.\n\n        Exclusion Criteria:\n\n          -  Age less than 18 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients who received Integra, free flap, local tissue flap, or negative pressure\n        wound therapy over a 5-year period.  The patient must be a minimum of 1 year from the\n        index procedure, any follow-up occurring during the year is eligible for inclusion."
            }
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01947387", 
            "org_study_id": "Integra 11-2011"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 6, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20007"
                    }, 
                    "name": "Georgetown University Hospital Wound Healing Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern University Feinberg School of Medicine Division of Plastic Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Brigham and Women's Hospital, Inc"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "9", 
        "official_title": "A Retrospective, Multi-Center Study Evaluating the Outcomes for Integra\u00ae Skin Sheet Bilayer or Single Layer Products Used in Complex Lower Extremity Soft Tissue Reconstruction", 
        "other_outcome": [
            {
                "measure": "Time to wound bed preparation for receipt of a split thickness skin graft (STSG) or dermoinductive agent after having received Integra or negative pressure wound therapy", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "Time to complete re-epithelization (as deemed by the surgeon) after Integra application or NPWT", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A dermoinductive agent is a product that is said to promote rapid wound healing.", 
            "measure": "Wound recurrence rates after Integra application (and final split-thickness skin graft or dermoinductive agent application) as compared with free flap, local tissue flap, and negative pressure wound therapy.", 
            "safety_issue": "No", 
            "time_frame": "5 year period"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01947387"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Time to ambulation/return to function after Integra application, free flap, local tissue flap, or negative pressure wound therapy.", 
            "safety_issue": "No", 
            "time_frame": "5 year period"
        }, 
        "source": "Integra LifeSciences Corporation", 
        "sponsors": {
            "collaborator": {
                "agency": "Georgetown University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Integra LifeSciences Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}